Displaying drugs 14876 - 14900 of 15538 in total
Adebrelimab
Adebrelimab is under investigation in clinical trial NCT03711305 (Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-stage (ES) Small Cell Lung Cancer (SCLC)).
Investigational
Quavonlimab
Quavonlimab is under investigation in clinical trial NCT03179436 (Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)).
Investigational
AK119
AK119 is a humanized anti-CD73 monoclonal antibody being investigated in the clinical trial NCT04516564 (A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects).
Investigational
Empasiprubart
Empasiprubart is a humanized sweeping antibody designed to bind to C2, a protein in the complement cascade that leads to cell destruction when activated.
Investigational
LSALT Peptide
Investigational
Biomodulin T
Biomodulin T is a polypeptide fraction from bovine thymus with immunomodulatory effects.
Investigational
KB109
KB109 is a prebiotic to feed healthy bacteria for them to to outcompete multi-drug resistance organisms.
Investigational
Lactobacillus fermentum
Experimental
Lactobacillus gasseri
Experimental
Bifidobacterium breve
Experimental
Bifidobacterium animalis lactis
Experimental
Gentiana lutea extract
Experimental
Bungarus candidus antivenom
Experimental
Wheat germ oil
Experimental
Tetanus immune globulin, equine
Experimental
Liprotamase protease
Experimental
Pygeum africanum bark
Experimental
Paeonia lactiflora root
Experimental
Artemisia annua leaf
Experimental
Citrus aurantium fruit
Experimental
Cinnamon leaf oil
Experimental
Fucus vesiculosus
Experimental
Cryptomeria japonica bark
Experimental
Cnidium monnieri fruit
Experimental
Zagotenemab
Zagotenemab is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease).
Investigational
Displaying drugs 14876 - 14900 of 15538 in total